Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.4M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
49.7M
-
Shares change
-
+34.2K
-
Total reported value, excl. options
-
$503M
-
Value change
-
-$98K
-
Put/Call ratio
-
0.66
-
Number of buys
-
83
-
Number of sells
-
-51
-
Price
-
$10.12
Significant Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q2 2023
171 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock as of Q2 2023.
2seventy bio, Inc. - Common Stock (TSVT) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.7M shares
of 52.4M outstanding shares and own 94.81% of the company stock.
Largest 10 shareholders include Kynam Capital Management, LP (4.89M shares), BlackRock Inc. (4.14M shares), VANGUARD GROUP INC (3.48M shares), STATE STREET CORP (3.06M shares), MILLENNIUM MANAGEMENT LLC (2.9M shares), WELLINGTON MANAGEMENT GROUP LLP (2.88M shares), BAKER BROS. ADVISORS LP (2.5M shares), ORBIMED ADVISORS LLC (2.39M shares), Casdin Capital, LLC (2.02M shares), and GOLDMAN SACHS GROUP INC (1.62M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.